- A nationwide recall of nearly 90,000 bottles of children's ibuprofen has been upgraded to a Class II recall by the Food and Drug Administration (FDA).
- Strides Pharma, Inc. initiated the recall after reports of a "gel-like mass and black particles" found in the Children’s Ibuprofen Oral Suspension, USP.
- The affected medication, distributed nationwide for Taro Pharmaceuticals USA, Inc., includes specific lot numbers 7261973A and 7261974A, with an expiration date of January 31, 2027.
- The FDA's Class II designation indicates that while the contaminated ibuprofen may pose temporary health risks, the probability of serious or permanent harm is low.
- No injuries or illnesses have been reported in connection with the recalled medication, but consumers are urged to stop using affected bottles and seek refunds or replacements.
IN FULL
